Grants and Contributions:
Title:
820221
Agreement Number:
820221
Agreement Value:
$31,250,000.00
Agreement Date:
Jul 22, 2026 - Dec 31, 2048
Description:
The project will establish an expanded commercial and manufacturing capacity to produce and sell the Globe pulsed field mapping and ablation system for the treatment of atrial fibrillation, a type of cardiac arrhythmia. The project’s work phase is scheduled to end on December 31, 2029.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
The project will establish domestic, world class manufacturing capabilities and capacity for highly advanced and regulated medical devices at a scale required to supply a large, rapidly expanding global market with advanced medical products developed and manufactured locally. This capacity does not currently exist in Canada.
Location:
Burnaby, British Columbia, CA V5J 0B6
Reference Number:
033-2026-2027-Q2-820221
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
827928326
Recipient Type:
For-profit organization
Additional Information:
N/A
Amendment Date
0001-01-01T00:00:00
Recipient's Operating Name:
Kardium Inc.
Recipient's Legal Name:
Kardium Inc.
Federal Riding Name:
Burnaby South
Federal Riding Number:
59003
Program:
Strategic Response Fund
Program Purpose:
Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services; Facilitate the growth and expansion of firms in Canada; Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
334512
Amendments: